The QSAR paradigm in the design of less toxic molecules.

[1]  N. B. Chapman,et al.  Correlation Analysis in Chemistry , 1978 .

[2]  Corwin Hansch.  Computerized Management of Structure-Activity Data. I. Multivariate Analysis of Biological Data. , 1974 .

[3]  Y. Martin,et al.  Quantitative drug design , 1978 .

[4]  A. Leo,et al.  Potential antitumor agents. 36. Quantitative relationships between experimental antitumor activity, toxicity, and structure for the general class of 9-anilinoacridine antitumor agents. , 1982, Journal of medicinal chemistry.

[5]  A. Leo,et al.  Substituent constants for correlation analysis. , 1977, Journal of medicinal chemistry.

[6]  R. Langridge,et al.  A Comparison by QSAR, Crystallography, and Computer Graphics of the Inhibition of Various Dihydrofolate Reductases by 5‐(X‐Benzyl)‐2,4‐diamino‐pyrimidines , 1982 .

[7]  G. Briggs,et al.  Theoretical and experimental relationships between soil adsorption, octanol-water partition-coefficients, water solubilities, bioconcentration factors, and the parachor , 1981 .

[8]  C. Hansch,et al.  Influence of hydrophobic character on the relative rate of oxidation of drugs by rat liver microsomes. , 1971, Journal of medicinal chemistry.

[9]  A. Leo,et al.  Antitumor structure-activity relations. Nitrosoureas vs. L-1210 leukemia. , 1980, Journal of medicinal chemistry.

[10]  C. T. Chiou,et al.  Partition equilibriums of nonionic organic compounds between soil organic matter and water. , 1983, Environmental science & technology.

[11]  P. N. Craig,et al.  Quantitative structure-activity relationships in 1-aryl-2-(alkylamino)ethanol antimalarials. , 1979, Journal of medicinal chemistry.

[12]  W J Dunn,et al.  Linear relationships between lipophilic character and biological activity of drugs. , 1972, Journal of pharmaceutical sciences.

[13]  Gary E. Blau,et al.  Partition coefficient to measure bioconcentration potential of organic chemicals in fish , 1974 .

[14]  C. Hansch.  Recent Advances in Biochemical QSAR , 1978 .

[15]  S. Unger.  Consequences of the Hansch Paradigm for the Pharmaceutical Industry , 1980 .

[16]  C. Hansch,et al.  Lipophilic character and biological activity of drugs. II. The parabolic case. , 1973, Journal of pharmaceutical sciences.

[17]  L. Hodes,et al.  A statistical-heuristic methods for automated selection of drugs for screening. , 1977, Journal of medicinal chemistry.

[18]  J M Blaney,et al.  Comparison of the inhibition of Escherichia coli and Lactobacillus casei dihydrofolate reductase by 2,4-diamino-5-(substituted-benzyl)pyrimidines: quantitative structure-activity relationships, X-ray crystallography, and computer graphics in structure-activity analysis. , 1982, Journal of medicinal chemistry.

[19]  W. Dunn,et al.  Chemicobiological interactions and the use of partition coefficients in their correlation. , 1974, Chemico-biological interactions.

[20]  G. Jolles,et al.  Drug design : fact or fantasy? , 1984 .

[21]  D. M. Brown,et al.  Structure-activity relationships of 1-substituted 2-nitroimidazoles: effect of partition coefficient and side-chain hydroxyl groups on radiosensitization in vitro. , 1982, Radiation research.

[22]  C. Hansch,et al.  p-σ-π Analysis. A Method for the Correlation of Biological Activity and Chemical Structure , 1964 .

[23]  C. Hansch,et al.  The correlation of localization rates of benzeneboronic acids in brain and tumor tissue with substituent constants. , 1965, Molecular pharmacology.

[24]  C. Hansch,et al.  A NEW SUBSTITUENT CONSTANT, PI, DERIVED FROM PARTITION COEFFICIENTS , 1964 .

[25]  C Hansch,et al.  Mutagenicity of substituted (o-phenylenediamine)platinum dichloride in the Ames test. A quantitative structure-activity analysis. , 1980, Journal of medicinal chemistry.

[26]  C. Hansch,et al.  Antitumor 1-(X-aryl)-3,3-dialkyltriazenes. 1. Quantitative structure-activity relationships vs. L1210 leukemia in mice. , 1978, Journal of medicinal chemistry.

[27]  C. Hansch,et al.  Ames test of 1-(X-phenyl)-3,3-dialkyltriazenes. A quantitative structure-activity study. , 1979, Journal of medicinal chemistry.

[28]  J. Topliss.  Quantitative structure-activity relationships of drugs , 1983 .

[29]  P. N. Craig.  Structure—Activity in Hazard Assessment , 1981 .

[30]  John F. Tinker.  Relating mutagenicity to chemical structure , 1981, J. Chem. Inf. Comput. Sci..

[31]  Gilman D. Veith,et al.  Measuring and Estimating the Bioconcentration Factor of Chemicals in Fish , 1979 .

[32]  P. N. Craig,et al.  Carcinogenesis: a predictive structure-activity model. , 1982, Journal of toxicology and environmental health.

[33]  T. Machinami,et al.  Synthesis and activities of antitumor agents. , 1979, Journal of medicinal chemistry.

[34]  A. Leo,et al.  Substituent constants for correlation analysis in chemistry and biology , 1979 .

[35]  J M Blaney,et al.  The use of crystallography, graphics, and quantitative structure--activity relationships in the analysis of the papain hydrolysis of X-phenyl hippurates. , 1982, Archives of biochemistry and biophysics.